Cargando…

An optimized platform for efficient siRNA delivery into human NK cells

The molecular networks that regulate natural killer (NK) cell functions are not completely understood. Here, we present a workflow for efficient delivery of siRNA into human NK cells without compromising viability. This methodology represents a promising approach for rapidly interrogating gene funct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palacios, Daniel, Momayyezi, Pouria, Huhn, Oisín, Ask, Eivind Heggernes, Dunst, Josefine, Malmberg, Karl‐Johan, Hammer, Quirin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Technical Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541389/ https://www.ncbi.nlm.nih.gov/pubmed/35416292 http://dx.doi.org/10.1002/eji.202149710

Ejemplares similares

SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells
por: Hammer, Quirin, et al.
Publicado: (2022)

Genome-wide screens for effective siRNAs through assessing the size of siRNA effects
por: Zhang, Xiaohua Douglas
Publicado: (2008)

MetaGate: Interactive Analysis of High-Dimensional Cytometry Data with Meta Data Integration
por: Ask, Eivind Heggernes, et al.
Publicado: (2023)

Non-viral siRNA delivery into the mouse retina in vivo
por: Turchinovich, Andrey, et al.
Publicado: (2010)

Remodeling of secretory lysosomes during education tunes functional potential in NK cells
por: Goodridge, Jodie P., et al.
Publicado: (2019)

Adaptive Natural Killer Cells Integrate Interleukin-18 during Target-Cell Encounter
por: Hammer, Quirin, et al.
Publicado: (2018)

Tracing dynamic expansion of human NK-cell subsets by high-resolution analysis of KIR repertoires and cellular differentiation
por: Béziat, Vivien, et al.
Publicado: (2014)

Mini-clusters with mean probabilities for identifying effective siRNAs
por: Xingang, Jia, et al.
Publicado: (2012)

Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB–siRNA conjugates
por: Cuellar, Trinna L., et al.
Publicado: (2015)

Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA
por: Elzeny, Hadeel, et al.
Publicado: (2017)

Targeted Delivery of siRNA
por: Oliveira, Sabrina, et al.
Publicado: (2006)

Dendrimers for siRNA Delivery
por: Biswas, Swati, et al.
Publicado: (2013)

Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles
por: Goldenson, Benjamin H., et al.
Publicado: (2020)

Water-soluble substituted chitosan derivatives as technology platform for inhalation delivery of siRNA
por: Capel, Victoria, et al.
Publicado: (2018)

Methods for siRNA-mediated Reduction of mRNA and Protein Expression in Human Placental Explants, Isolated Primary Cells and Cell Lines
por: Forbes, K., et al.
Publicado: (2009)

Adaptive single-KIR(+)NKG2C(+) NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia
por: Haroun-Izquierdo, Alvaro, et al.
Publicado: (2022)

Aptamer mediated siRNA delivery
por: Chu, Ted C., et al.
Publicado: (2006)

Pulmonary delivery of therapeutic siRNA
por: Lam, Jenny Ka-Wing, et al.
Publicado: (2012)

Intranasal Delivery of Antiviral siRNA
por: Barik, Sailen
Publicado: (2010)

Drug Delivery of siRNA Therapeutics
por: Lamberti, Gaetano, et al.
Publicado: (2020)

Comparative route of administration studies using therapeutic siRNAs show widespread gene modulation in Dorset sheep
por: Ferguson, Chantal M., et al.
Publicado: (2021)

A supramolecular platform for controlling and optimizing molecular architectures of siRNA targeted delivery vehicles
por: Wen, Yuting, et al.
Publicado: (2020)

PFRED: A computational platform for siRNA and antisense oligonucleotides design
por: Sciabola, Simone, et al.
Publicado: (2021)

Targeted siRNA nanocarrier: a platform technology for cancer treatment
por: Bäumer, Nicole, et al.
Publicado: (2022)

Albumin pre-coating enhances intracellular siRNA delivery of multifunctional amphiphile/siRNA nanoparticles
por: Kummitha, China M, et al.
Publicado: (2012)

Disulfide-Based Poly(amido amine)s for siRNA Delivery: Effects of Structure on siRNA Complexation, Cellular Uptake, Gene Silencing and Toxicity
por: Vader, Pieter, et al.
Publicado: (2010)

Prospects for NK Cell Therapy of Sarcoma
por: Lachota, Mieszko, et al.
Publicado: (2020)

Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription
por: Jang, Mihue, et al.
Publicado: (2015)

Advances in Lipid Nanoparticles for siRNA Delivery
por: Tam, Yuen Yi C., et al.
Publicado: (2013)

Bone site-specific delivery of siRNA
por: Liu, Xinli
Publicado: (2016)

Chaperonin–Dendrimer Conjugates for siRNA Delivery
por: Nussbaumer, Martin G., et al.
Publicado: (2016)

Amphiphilic Peptides for Efficient siRNA Delivery
por: Mozaffari, Saghar, et al.
Publicado: (2019)

Non-viral siRNA delivery to the lung()
por: Thomas, Mini, et al.
Publicado: (2007)

Nanoscale Particles for Lung Delivery of siRNA
por: Nascimento, T.L., et al.
Publicado: (2012)

Centyrin ligands for extrahepatic delivery of siRNA
por: Klein, Donna, et al.
Publicado: (2021)

BSA Nanoparticles for siRNA Delivery: Coating Effects on Nanoparticle Properties, Plasma Protein Adsorption, and In Vitro siRNA Delivery
por: Yogasundaram, Haran, et al.
Publicado: (2012)

Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014)

Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
por: Berezhnoy, Alexey, et al.
Publicado: (2012)

Where should siRNAs go: applicable organs for siRNA drugs
por: Ahn, Insook, et al.
Publicado: (2023)

High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNA
por: Ye, Junxiao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1j9tbsbu7urfmvnvnf7uvh01pt